World Lung Conference 2024 Abstract. Oral treatment shows promise in her2.  — the data was presented today at the international association for the study.

 — daiichi sankyo and merck & co’s fast move into phase 3 with ifinatamab.  — presented at the 2024 world conference on lung cancer;